Diagnostic Differentiation Between Arrhythmogenic Cardiomyopathy and Athlete’s Heart by Using Imaging (JACC: Cardiovascular Imaging September 2018) is organized by American College of Cardiology (ACC).
Date of Release: September 3, 2018
Term of Approval/Date of CME/MOC Expiration: September 2, 2019
JACC Journal CME/MOC is intended for physicians who treat patients with cardiovascular disease.
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an important cause of sudden cardiac death (SCD) in youth and athletes. In the last decade, several studies focused on right ventricular (RV) remodeling in athletes and revealed that features of the physiological adaptation of the right heart to training, such as RV dilation, may overlap with those of ARVC. Therefore, a careful multiparametric evaluation is required for differential diagnosis in order to avoid false diagnosis of ARVC or, in contrast, fail to identify of the risk of causing SCD. This review summarizes physiological adaptation of the RV to exercise and describes features that could help distinguishing between athlete’s heart and ARVC.
After reading this article the reader should be able to:
• Define current approaches for the evaluation, management, and prevention of cancer therapy related cardiac dysfunction before, during, and after cancer therapy.
• Recognize the spectrum of echocardiographic phenotype of cancer therapy related cardiac dysfunction and the use of echocardiography in the diagnosis, management, and risk stratification.
• Summarize current cardio-oncology imaging practices and the role of echocardiography in guiding clinical decision making for patients during and after cancer therapy.
Additional details will be posted as soon as they are available.